Nanjing Innocare Pharma Tech Co., Ltd.

Chine

Commandez votre montre hebdomadaire Nanjing Innocare Pharma Tech Co., Ltd.
Quantité totale PI 9
Rang # Quantité totale PI 175 625
Note d'activité PI 1,8/5.0    10
Rang # Activité PI 89 810

Brevets

Marques

0 0
1 0
8 0
0
 
Dernier brevet 2025 - Heterocyclic compound as ripk1 i...
Premier brevet 2017 - Heterocyclic compound used as fg...

Derniers inventions, produits et services

2025 Invention Heterocyclic compound as ripk1 inhibitor. The present invention relates to a compound of formula ...
2023 Invention Heterocyclic compound as ripk1 inhibitor. The present invention relates to a compound, a pharmace...
Invention Crystal form of compound and preparation method therefor. The present invention relates to a crys...
2022 Invention Heterocyclic compound as bcl-2 inhibitor. Provided in the present invention are a heterocyclic co...
2021 Invention Novel compound as rearranged during transfection kinase inhibitor. The present invention relates ...
2019 Invention Heterocyclic compounds used as fgfr inhibitors. The present invention relates to a heterocyclic c...
2018 Invention Heterocyclic compounds as mnk inhibitors. The present invention relates to a heterocyclic compou...
Invention Heterocyclic compound used as mnk inhibitor. The present invention relates to a heterocyclic comp...
2017 Invention Heterocyclic compound used as fgfr inhibitor. The present invention relates to a heterocyclic com...